Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Prognostic Impact of Immune-Related Adverse Events As First-Line Therapy for Metastatic Renal Cell Carcinoma Treated with Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study.

Takuhisa Nukaya,Kiyoshi Takahara,Atsuhiko Yoshizawa,Masanobu Saruta,Yusuke Yano,Takaya Ohno,Taizo Uchimoto,Wataru Fukuokaya,Takahiro Adachi,Shogo Yamazaki,Satoshi Tokushige,Kazuki Nishimura,Takuya Tsujino,Keita Nakamori,Shutaro Yamamoto,Kosuke Iwatani,Fumihiko Urabe,Keiichiro Mori,Takafumi Yanagisawa,Shunsuke Tsuduki,Yosuke Hirasawa,Takeshi Hashimoto,Kazumasa Komura,Teruo Inamoto,Jun Miki,Takahiro Kimura,Yoshio Ohno,Haruhito Azuma,Ryoichi Shiroki

CLINICAL GENITOURINARY CANCER（2024）

Cited 0|Views30
Key words
Metastatic renal cell carcinoma,Immune-related adverse events,Nivolumab plus ipilimumab,OS predictors,First-line therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined